(Q38655231)

5 September 2017

Approaches for the vaccination and treatment of Neospora caninum infections in mice and ruminant models (English)

1 reference

5 September 2017

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Andrew Hemphill

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Adriana Aguado-Martínez

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

publication date

2 December 2015

1 reference

5 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

245-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

Mice congenitally infected with low-to-moderate virulence Neospora caninum isolates exhibited clinical reactivation during the mating period without transmission to the next generation

8 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Low rates of Neospora caninum infection reactivation during gestation are observed in both chronically and congenitally infected mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-ε-caprolactone against Neospora caninum infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Generation and immunity testing of a recombinant adenovirus expressing NcSRS2-NcGRA7 fusion protein of bovine Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Potent and Selective Inhibitors of CDPK1 from T. gondii and C. parvum Based on a 5-Aminopyrazole-4-carboxamide Scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccines against Toxoplasma gondii: new developments and perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

A Neospora caninum vaccine using recombinant proteins fails to prevent foetal infection in pregnant cattle after experimental intravenous challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immune response and protection provided by live tachyzoites and native antigens from the NC-6 Argentina strain of Neospora caninum in pregnant heifers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

[Epidemiological and financial considerations for the control of Neospora caninum on Swiss dairy farms]

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Simulating the impact of four control strategies on the population dynamics of Neospora caninum infection in Swiss dairy cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Financial analysis of various strategies for the control of Neospora caninum in dairy cattle in Switzerland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Possible mode of action of toltrazuril: studies on two Eimeria species and mammalian and Ascaris suum enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Humoral immune reaction of newborn calves congenitally infected with Neospora caninum and experimentally treated with toltrazuril.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Toltrazuril treatment to control diaplacental Neospora caninum transmission in experimentally infected pregnant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

In Vitro and In Vivo Effects of the Bumped Kinase Inhibitor 1294 in the Related Cyst-Forming Apicomplexans Toxoplasma gondii and Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Endogenous and exogenous transplacental transmission of Neospora caninum - how the route of transmission impacts on epidemiology and control of disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

First demonstration of protective immunity against foetopathy in cattle with latent Neospora caninum infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Protecting babies: vaccine strategies to prevent foetopathy in Neospora caninum-infected cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Dose-titration challenge of young pregnant sheep with Neospora caninum tachyzoites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

On the efficacy and safety of vaccination with live tachyzoites of Neospora caninum for prevention of neospora-associated fetal loss in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Discovering a vaccine against neosporosis using computers: is it feasible?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Neospora caninum in wildlife

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Type 1 and type 2 responses in regulation of Ig isotype expression in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccination with gamma-irradiated Neospora caninum tachyzoites protects mice against acute challenge with N. caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

In vitro efficacies of nitazoxanide and other thiazolides against Neospora caninum tachyzoites reveal antiparasitic activity independent of the nitro group

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

A vaccine formulation combining rhoptry proteins NcROP40 and NcROP2 improves pup survival in a pregnant mouse model of neosporosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Epidemiology and control of neosporosis and Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccination of ewes for prevention of vertical transmission of Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Neospora caninum induced abortion in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Oligomannose-coated liposome-entrapped dense granule protein 7 induces protective immune response to Neospora caninum in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Review of Neospora caninum and neosporosis in animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immunization of dogs with a canine herpesvirus vector expressing Neospora caninum surface protein, NcSRS2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immunization of cattle using varying infective doses of Theileria parva lawrencei sporozoites derived from an African buffalo (Syncerus caffer) and treatment with buparvaquone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Control of clinical coccidiosis of calves due to Eimeria bovis and Eimeria zuernii with toltrazuril under field conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

In vitro effects of new artemisinin derivatives in Neospora caninum-infected human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Comparative study of protective activities of Neospora caninum bradyzoite antigens, NcBAG1, NcBSR4, NcMAG1, and NcSAG4, in a mouse model of acute parasitic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immunization of female BALB/c mice with Neospora cyclophilin and/or NcSRS2 elicits specific antibody response and prevents against challenge infection by Neospora caninum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Bovine gamma delta T cells and the function of gamma delta T cell specific WC1 co-receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Toltrazuril treatment of congenitally acquired Neospora caninum infection in newborn mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Treatment of mice with the anticoccidial drug Toltrazuril does not interfere with the development of a specific cellular intestinal immune response to Eimeria falciformis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Identification of vaccine candidate peptides in the NcSRS2 surface protein of Neospora caninum by using CD4+ cytotoxic T lymphocytes and gamma interferon-secreting T lymphocytes of infected holstein cattle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Understanding the basis of parasite strain-restricted immunity to Theileria parva.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Occurrence of Neospora caninum and Toxoplasma gondii infections in ovine and caprine abortions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Neosporosis in South America

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Use of a Th1 Stimulator Adjuvant for Vaccination against Neospora caninum Infection in the Pregnant Mouse Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

RecNcMIC3-1-R is a microneme- and rhoptry-based chimeric antigen that protects against acute neosporosis and limits cerebral parasite load in the mouse model for Neospora caninum infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccines against neosporosis: what can we learn from the past studies?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Drug repurposing: mining protozoan proteomes for targets of known bioactive compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

A review on human toxoplasmosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Spiroindolones, a potent compound class for the treatment of malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The sylvatic cycle of Neospora caninum: where do we go from here?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Effect of vaccination of cattle with the low virulence Nc-Spain 1H isolate of Neospora caninum against a heterologous challenge in early and mid-gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Emerging protein targets for anticancer metallodrugs: inhibition of thioredoxin reductase and cathepsin B by antitumor ruthenium(II)-arene compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The comparative pathogenesis of neosporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Reduction in transplacental transmission of Neospora caninum in outbred mice by vaccination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Experimental neosporosis in pregnant ewes and their offspring

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Na(+) regulation in the malaria parasite Plasmodium falciparum involves the cation ATPase PfATP4 and is a target of the spiroindolone antimalarials

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Novel amidines and analogues as promising agents against intracellular parasites: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Experimental treatment of Neospora caninum-infected mice with the arylimidamide DB750 and the thiazolide nitazoxanide

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Thiazolides inhibit growth and induce glutathione-S-transferase Pi (GSTP1)-dependent cell death in human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Differential effects of intranasal vaccination with recombinant NcPDI in different mouse models of Neospora caninum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

New approaches for the identification of drug targets in protozoan parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Effects of miltefosine treatment in fibroblast cell cultures and in mice experimentally infected with Neospora caninum tachyzoites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

In vitro culture systems for the study of apicomplexan parasites in farm animals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Anticancer Effect of AntiMalarial Artemisinin Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Drug target identification in intracellular and extracellular protozoan parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Histological and immunohistochemical characterization of the inflammatory and glial cells in the central nervous system of goat fetuses and adult male goats naturally infected with Neospora caninum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Influence of the gestational stage on the clinical course, lesional development and parasite distribution in experimental ovine neosporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Dose-dependent effects of experimental infection with the virulent Neospora caninum Nc-Spain7 isolate in a pregnant mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Experimental infection of non-pregnant and pregnant sheep with Neospora caninum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Successful vaccines for naturally occurring protozoal diseases of animals should guide human vaccine research. A review of protozoal vaccines and their designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The effect of a live Neospora caninum tachyzoite vaccine in naturally infected pregnant dairy cows

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Neospora caninum: in vivo and in vitro treatment with artemisone

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Immune response profile elicited by the model antigen ovalbumin expressed in fusion with the bacterial OprI lipoprotein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Coccidiosis control with toltrazuril in conjunction with anticoccidial medicated or nonmedicated feed

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Dose-dependent immunogenicity of a soluble Neospora caninum tachyzoite-extract vaccine formulated with a soy lecithin/β-glucan adjuvant in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Calcium-dependent protein kinase 1 is an essential regulator of exocytosis in Toxoplasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Evaluation of the protection conferred by a naturally attenuated Neospora caninum isolate against congenital and cerebral neosporosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Control options for Neospora caninum--is there anything new or are we going backwards?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

What is the global economic impact of Neospora caninum in cattle - the billion dollar question.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Neospora caninum--how close are we to development of an efficacious vaccine that prevents abortion in cattle?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Prevention of lethal experimental infection of C57BL/6 mice by vaccination with Brucella abortus strain RB51 expressing Neospora caninum antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Optimization of the use of C57BL/6 mice as a laboratory animal model for Neospora caninum vaccine studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Influence of Neospora caninum infection in BALB/c mice during pregnancy in post-natal development

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The proteasome inhibitor MLN-273 blocks exoerythrocytic and erythrocytic development of Plasmodium parasites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The adaptive potential of a survival artist: characterization of the in vitro interactions of Toxoplasma gondii tachyzoites with di-cationic compounds in human fibroblast cell cultures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

An explorative study to assess the efficacy of toltrazuril-sulfone (ponazuril) in calves experimentally infected with Neospora caninum

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The use of anticancer drugs in antiparasitic chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

The gatekeeper residue and beyond: homologous calcium-dependent protein kinases as drug development targets for veterinarian Apicomplexa parasites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

A new cloning system based on the OprI lipoprotein for the production of recombinant bacterial cell wall-derived immunogenic formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

In vitro effects of novel ruthenium complexes in Neospora caninum and Toxoplasma gondii tachyzoites

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

A live vaccine against Neospora caninum abortions in cattle

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

If control of Neospora caninum infection is technically feasible does it make economic sense?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

Comparison of Babesia rossi and Babesia canis isolates with emphasis on effects of vaccination with soluble parasite antigens: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

NcGRA2 as a molecular target to assess the parasiticidal activity of toltrazuril against Neospora caninum

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Transgenic Neospora caninum strains constitutively expressing the bradyzoite NcSAG4 protein proved to be safe and conferred significant levels of protection against vertical transmission when used as live vaccines in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Neospora caninum calcium-dependent protein kinase 1 is an effective drug target for neosporosis therapy

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Immunity to experimental neosporosis in pregnant sheep

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

The role of B- and T-cell immunity in toltrazuril-treated C57BL/6 WT, microMT and nude mice experimentally infected with Neospora caninum

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Evaluation of vaccination with Neospora caninum protein for prevention of fetal loss associated with experimentally induced neosporosis in sheep

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Economic considerations for diagnostic and control options for Neospora caninum-induced abortions in endemically infected herds of beef cattle

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Proteins mediating the Neospora caninum-host cell interaction as targets for vaccination.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Targeting TLR2 for vaccine development

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

The immune enhancement of a novel soy lecithin/β-glucans based adjuvant on native Neospora caninum tachyzoite extract vaccine in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Antigen-specific CD8+ T cells protect against lethal toxoplasmosis in mice infected with Neospora caninum

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Self-adjuvanting glycopeptide conjugate vaccine against disseminated candidiasis

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Evaluation of an inactivated Neospora caninum vaccine in beef feedlot steers

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Construction of Neospora caninum stably expressing TgSAG1 and evaluation of its protective effects against Toxoplasma gondii infection in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Efficacy of a Neospora caninum killed tachyzoite vaccine in preventing abortion and vertical transmission in dairy cattle

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Tuning the hydrophobicity of ruthenium(II)-arene (RAPTA) drugs to modify uptake, biomolecular interactions and efficacy

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Neospora caninum infection as a cause of reproductive failure in a sheep flock

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Bombyx mori nucleopolyhedrovirus displaying neospora caninum antigens as a vaccine candidate against N. caninum infection in mice

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

Development of molecular genetics for Neospora caninum: A complementary system to Toxoplasma gondii

1 reference

https://api.crossref.org/works/10.1017%2FS0031182015001596

7 January 2021

10.1017/S0031182015001596

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26626124%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference